ask="6.40"
ask_size="1000"
average_daily_volume="880594"
bid="5.95"
bid_size="1000"
book_value="0.05"
change="-0.12"
change_from_200_day_moving_average="1.51"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-3.20"
change_From_52_week_low="4.44"
change_in_percent="-1.94%"
close="6.07"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.91"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="46288000"
high="6.42"
high_52_weeks="9.27"
last_trade_date="1/11/2017"
last_trade_price="6.07"
last_trade_size="46807"
last_trade_time="4:00pm"
low="5.85"
low_52_weeks="1.63"
market_capitalization="447.71M"
moving_average_200_day="4.56"
moving_average_50_day="6.08"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.08"
open="6.16"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+33.22%"
percent_change_from_50_day_moving_average="-0.18%"
percent_change_from_52_week_high="-34.52%"
percent_change_from_52_week_low="+272.39%"
previous_close="6.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="114.63"
price_per_sales="20.78"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="13.23"
stock_exchange="NMS"
symbol="BCRX"
volume="1486358"
weeks_range_52="1.63 - 9.27"
